Register entry

EyePoint US, Inc.

Data as of · How to read this entry

Registered sites
2
Active NDC listings
0
Live patents
5
Countries
1
Base
United States
Authorisation

Registered operations

Analytical testing1Labelling2Finished drug manufacture2Packaging1
Sites

Registered establishments

2
EstablishmentAddressRegistered forFEI / DUNS
EyePoint US, Inc.600 Commerce Dr, Northbridge, Massachusetts (MA) 01534, United States (USA)Analytical testing, Labelling, Finished drug manufacture, Packaging3036800967145005529
EyePoint US, Inc.480 Pleasant Street B300, Watertown, Massachusetts (MA) 02472, United States (USA)Labelling, Finished drug manufacture3005508657968003785
Exclusivity

Patents and exclusivities

5
PatentProductCoversExpiry
10799642DEXYCU KITdexamethasoneproductMay 2032
10028965DEXYCU KITdexamethasoneuseMay 2034
10159683DEXYCU KITdexamethasoneproductMay 2034
10022502DEXYCU KITdexamethasoneuseJun 2034
11097061DEXYCU KITdexamethasoneproductJun 2039
Compare

Comparable companies in United States

Enquiry

Common questions

Is EyePoint US, Inc. FDA approved?
EyePoint US, Inc. holds 2 FDA-registered establishments in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are EyePoint US, Inc.'s drugs manufactured?
The FDA register lists Northbridge, MA; Watertown, MA. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.